Collection 3 (Sep 2022 - Aug 2023) Articles

Articles
Treatment gaps in the implementation of LDL cholesterol control among high- and very high-risk patients in Europe between 2020 and 2021: the multinational observational SANTORINI study
Ray KK, Haq I, Bilitou A, et al.
Journal:
Lancet Reg Health Eur

First published: April 5, 2023 DOI: 10.1016/j.lanepe.2023.100624
View
- Share
Articles
Alirocumab and Coronary Atherosclerosis in Asymptomatic Patients with Familial Hypercholesterolemia: The ARCHITECT Study
Pérez de Isla L, Díaz-Díaz JL, Romero MJ, et al.
Journal:
Circulation

First published: April 3, 2023 DOI: 10.1161/CIRCULATIONAHA.122.062557
View
- Share
Articles
Combination Moderate-Intensity Statin and Ezetimibe Therapy for Elderly Patients With Atherosclerosis
Lee SH, Lee YJ, Heo JH, et al.
Journal:
J Am Coll Cardiol

First published: April 3, 2023 DOI: 10.1016/j.jacc.2023.02.007
View
- Share
Articles
Exercise benefits in cardiovascular diseases: from mechanisms to clinical implementation
Valenzuela PL, Ruilope LM, Santos-Lozano A, et al.
Journal:
Eur Heart J

First published: April 3, 2023 DOI: 10.1093/eurheartj/ehad170
View
- Share
Articles
Lipoprotein(a): cardiovascular risk and emerging therapies
Fujino M, Nicholls SJ
Journal:
Expert Rev Cardiovasc Ther

First published: April 3, 2023 DOI: 10.1080/14779072.2023.2197593
View
- Share
Articles
Proteomics and lipidomics in atherosclerotic cardiovascular disease risk prediction
Nurmohamed NS, Kraaijenhof JM, Mayr M, et al.
Journal:
Eur Heart J

First published: March 29, 2023 DOI: 10.1093/eurheartj/ehad161
View
- Share
Articles
Subclinical Coronary Atherosclerosis and Risk for Myocardial Infarction in a Danish Cohort: A Prospective Observational Cohort Study
Fuchs A, Kühl JT, Sigvardsen PE, et al.
Journal:
Ann Intern Med

First published: March 23, 2023 DOI: 10.7326/M22-3027
View
- Share
Articles
Prevalence of Statin Use for Primary Prevention of Atherosclerotic Cardiovascular Disease by Race, Ethnicity, and 10-Year Disease Risk in the US: National Health and Nutrition Examination Surveys, 2013 to March 2020
Jacobs JA, Addo DK, Zheutlin AR, et al.
Journal:
JAMA Cardiol

First published: March 22, 2023 DOI: 10.1001/jamacardio.2023.0228
View
- Share
Articles
Efficacy and safety of the oral PCSK9 inhibitor MK-0616: a phase 2b randomized controlled trial
Ballantyne CM, Banka P, Mendez G, et al.
Journal:
J Am Coll Cardiol

First published: March 6, 2023 DOI: 10.1016/j.jacc.2023.02.018
View
- Share
Articles
Inflammation and cholesterol as predictors of cardiovascular events among patients receiving statin therapy: a collaborative analysis of three randomised trials
Ridker PM, Bhatt DL, Pradhan AD, et al.
Journal:
Lancet

First published: March 6, 2023 DOI: 10.1016/S0140-6736(23)00215-5
View
- Share
Articles
PROMINENT, REDUCE-IT, and STRENGTH Investigators. Inflammation and cholesterol as predictors of cardiovascular events among patients receiving statin therapy: a collaborative analysis of three randomised trials
Ridker PM, Bhatt DL, Pradhan AD, et al.
Journal:
Lancet

First published: March 6, 2023 DOI: 10.1016/S0140-6736(23)00215-5
View
- Share
Articles
Cluster Randomized Trial of a Personalized Clinical Decision Support Intervention to Improve Statin Prescribing in Patients With Atherosclerotic Cardiovascular Disease
Virani SS, Ramsey DJ, Westerman D, et al.
Journal:
Circulation

First published: March 5, 2023 DOI: 10.1161/CIRCULATIONAHA.123.064226
View
- Share

1 2 3 4 5 … 8

Collection 3 (Sep 2022 - Aug 2023) Articles

Articles

Treatment gaps in the implementation of LDL cholesterol control among high- and very high-risk patients in Europe between 2020 and 2021: the multinational observational SANTORINI study

Ray KK, Haq I, Bilitou A, et al.

Articles

Alirocumab and Coronary Atherosclerosis in Asymptomatic Patients with Familial Hypercholesterolemia: The ARCHITECT Study

Pérez de Isla L, Díaz-Díaz JL, Romero MJ, et al.

Articles

Combination Moderate-Intensity Statin and Ezetimibe Therapy for Elderly Patients With Atherosclerosis

Lee SH, Lee YJ, Heo JH, et al.

Articles

Exercise benefits in cardiovascular diseases: from mechanisms to clinical implementation

Valenzuela PL, Ruilope LM, Santos-Lozano A, et al.

Articles

Lipoprotein(a): cardiovascular risk and emerging therapies

Fujino M, Nicholls SJ

Articles

Proteomics and lipidomics in atherosclerotic cardiovascular disease risk prediction

Nurmohamed NS, Kraaijenhof JM, Mayr M, et al.

Articles

Subclinical Coronary Atherosclerosis and Risk for Myocardial Infarction in a Danish Cohort: A Prospective Observational Cohort Study

Fuchs A, Kühl JT, Sigvardsen PE, et al.

Articles

Prevalence of Statin Use for Primary Prevention of Atherosclerotic Cardiovascular Disease by Race, Ethnicity, and 10-Year Disease Risk in the US: National Health and Nutrition Examination Surveys, 2013 to March 2020

Jacobs JA, Addo DK, Zheutlin AR, et al.

Articles

Efficacy and safety of the oral PCSK9 inhibitor MK-0616: a phase 2b randomized controlled trial

Ballantyne CM, Banka P, Mendez G, et al.

Articles

Inflammation and cholesterol as predictors of cardiovascular events among patients receiving statin therapy: a collaborative analysis of three randomised trials

Ridker PM, Bhatt DL, Pradhan AD, et al.

Articles

PROMINENT, REDUCE-IT, and STRENGTH Investigators. Inflammation and cholesterol as predictors of cardiovascular events among patients receiving statin therapy: a collaborative analysis of three randomised trials

Ridker PM, Bhatt DL, Pradhan AD, et al.

Articles

Cluster Randomized Trial of a Personalized Clinical Decision Support Intervention to Improve Statin Prescribing in Patients With Atherosclerotic Cardiovascular Disease

Virani SS, Ramsey DJ, Westerman D, et al.

Articles

Treatment gaps in the implementation of LDL cholesterol control among high- and very high-risk patients in Europe between 2020 and 2021: the multinational observational SANTORINI study

Ray KK, Haq I, Bilitou A, et al.

Share

Articles

Alirocumab and Coronary Atherosclerosis in Asymptomatic Patients with Familial Hypercholesterolemia: The ARCHITECT Study

Pérez de Isla L, Díaz-Díaz JL, Romero MJ, et al.

Share

Articles

Combination Moderate-Intensity Statin and Ezetimibe Therapy for Elderly Patients With Atherosclerosis

Lee SH, Lee YJ, Heo JH, et al.

Share

Articles

Exercise benefits in cardiovascular diseases: from mechanisms to clinical implementation

Valenzuela PL, Ruilope LM, Santos-Lozano A, et al.

Share

Articles

Lipoprotein(a): cardiovascular risk and emerging therapies

Fujino M, Nicholls SJ

Share

Articles

Proteomics and lipidomics in atherosclerotic cardiovascular disease risk prediction

Nurmohamed NS, Kraaijenhof JM, Mayr M, et al.

Share

Articles

Subclinical Coronary Atherosclerosis and Risk for Myocardial Infarction in a Danish Cohort: A Prospective Observational Cohort Study

Fuchs A, Kühl JT, Sigvardsen PE, et al.

Share

Articles

Prevalence of Statin Use for Primary Prevention of Atherosclerotic Cardiovascular Disease by Race, Ethnicity, and 10-Year Disease Risk in the US: National Health and Nutrition Examination Surveys, 2013 to March 2020

Jacobs JA, Addo DK, Zheutlin AR, et al.

Share

Articles

Efficacy and safety of the oral PCSK9 inhibitor MK-0616: a phase 2b randomized controlled trial

Ballantyne CM, Banka P, Mendez G, et al.

Share

Articles

Inflammation and cholesterol as predictors of cardiovascular events among patients receiving statin therapy: a collaborative analysis of three randomised trials

Ridker PM, Bhatt DL, Pradhan AD, et al.

Share

Articles

PROMINENT, REDUCE-IT, and STRENGTH Investigators. Inflammation and cholesterol as predictors of cardiovascular events among patients receiving statin therapy: a collaborative analysis of three randomised trials

Ridker PM, Bhatt DL, Pradhan AD, et al.

Share

Articles

Cluster Randomized Trial of a Personalized Clinical Decision Support Intervention to Improve Statin Prescribing in Patients With Atherosclerotic Cardiovascular Disease

Virani SS, Ramsey DJ, Westerman D, et al.

Share